Cytosorbents Ownership 2024 | Who Owns Cytosorbents Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

16.81%

Insider Ownership

3.20%

Retail Ownership

79.99%

Institutional Holders

26.00

Cytosorbents Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AVENIR CORP7.10%0.26%3,172,696121,2943.98%3,014,061Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC6.82%0.10%3,044,833-573,310-15.85%2,892,591Mar 31, 2024
SKYLANDS CAPITAL, LLC6.44%0.38%2,875,552-378,661-11.64%2,731,774Mar 31, 2024
VANGUARD GROUP INC4.37%-1,949,551--1,852,074Mar 31, 2024
NEUBERGER BERMAN GROUP LLC4.28%0.00%1,912,566110,7676.15%1,812,501Mar 31, 2024
SARGENT INVESTMENT GROUP, LLC3.06%0.28%1,366,31957,5724.40%1,298,003Mar 31, 2024
CM MANAGEMENT, LLC1.85%0.66%825,000410,00098.80%783,750Mar 31, 2024
BLACKROCK INC.1.62%-722,435-3,885-0.53%686,313Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.98%-438,29773,37720.11%416,474Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.39%0.00%172,649--156,938,000Mar 31, 2024
STATE STREET CORP0.31%-140,293-10,800-7.15%133,278Mar 31, 2024
MORGAN STANLEY0.26%-116,385-3,593-2.99%110,566Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.25%0.00%113,8101,1000.98%108,120,000Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.18%0.00%79,620-95,700-54.59%76,000Mar 31, 2024
NORTHERN TRUST CORP0.17%-75,013--71,262Mar 31, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.14%0.00%60,591--57,561Mar 31, 2024
RAYMOND JAMES & ASSOCIATES0.11%-50,000--47,500Mar 31, 2024
JANE STREET GROUP, LLC0.10%-46,65546,655100.00%44,322Mar 31, 2024
STIFEL FINANCIAL CORP0.10%-45,000--42,750Mar 31, 2024
BANK OF AMERICA CORP /DE/0.08%-36,898-29,882-44.75%35,053,000Mar 31, 2024

Cytosorbents's largest institutional shareholder is AVENIR CORP, holding 7.10% of the company's total share outstanding, currently valued at $3.01M. The top 10 institutional shareholders own together 36.90% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CM MANAGEMENT, LLC1.85%0.66%825,000410,00098.80%783,750Mar 31, 2024
SKYLANDS CAPITAL, LLC6.44%0.38%2,875,552-378,661-11.64%2,731,774Mar 31, 2024
SARGENT INVESTMENT GROUP, LLC3.06%0.28%1,366,31957,5724.40%1,298,003Mar 31, 2024
AVENIR CORP7.10%0.26%3,172,696121,2943.98%3,014,061Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC6.82%0.10%3,044,833-573,310-15.85%2,892,591Mar 31, 2024
SEELAUS ASSET MANAGEMENT LLC0.04%0.02%18,950--18,003Mar 31, 2024
KEY CLIENT FIDUCIARY ADVISORS, LLC0.08%0.02%34,55722,557187.97%32,829Mar 31, 2024
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC0.05%0.00%23,166-7,500-24.46%22,008Mar 31, 2024
NEUBERGER BERMAN GROUP LLC4.28%0.00%1,912,566110,7676.15%1,812,501Mar 31, 2024
CHICAGO PARTNERS INVESTMENT GROUP LLC0.07%0.00%30,667-169-0.55%26,956Mar 31, 2024
COUNTRY CLUB BANK /GFN0.03%0.00%15,225--14,463Mar 31, 2024
REGAL INVESTMENT ADVISORS LLC0.03%0.00%11,509-34,315-74.88%10,934Mar 31, 2024
HEXAGON CAPITAL PARTNERS LLC0.01%0.00%3,333--3,166Mar 31, 2024
SOA WEALTH ADVISORS, LLC.0.01%0.00%2,222--2,111,000Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.39%0.00%172,649--156,938,000Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.25%0.00%113,8101,1000.98%108,120,000Mar 31, 2024
RESOURCES INVESTMENT ADVISORS, LLC.0.03%0.00%15,000--14,250Mar 31, 2024
JOHNSON INVESTMENT COUNSEL INC0.04%0.00%19,387-584-2.92%18,418Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.02%0.00%8,0241,86930.37%7,623Mar 31, 2024
BRADLEY FOSTER & SARGENT INC/CT0.02%0.00%10,000--9,500Mar 31, 2024

The largest Cytosorbents shareholder by % of total assets is CM MANAGEMENT, LLC. The company owns 825.00K shares of Cytosorbents (CTSO), representing 0.66% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CM MANAGEMENT, LLC1.85%0.66%825,000410,00098.80%783,750Mar 31, 2024
AVENIR CORP7.10%0.26%3,172,696121,2943.98%3,014,061Mar 31, 2024
NEUBERGER BERMAN GROUP LLC4.28%0.00%1,912,566110,7676.15%1,812,501Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.98%-438,29773,37720.11%416,474Mar 31, 2024
SARGENT INVESTMENT GROUP, LLC3.06%0.28%1,366,31957,5724.40%1,298,003Mar 31, 2024
JANE STREET GROUP, LLC0.10%-46,65546,655100.00%44,322Mar 31, 2024
KEY CLIENT FIDUCIARY ADVISORS, LLC0.08%0.02%34,55722,557187.97%32,829Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.04%-16,19816,198100.00%15,388Mar 31, 2024
SEI INVESTMENTS CO0.03%-14,4714,07039.13%13,850Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.02%0.00%8,0241,86930.37%7,623Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.25%0.00%113,8101,1000.98%108,120,000Mar 31, 2024
COMERICA BANK0.00%-83731861.27%795,000Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-79625547.13%757,000Mar 31, 2024
LAZARD ASSET MANAGEMENT LLC0.00%-1,09015216.20%1,000Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--1--1Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC--3--3Mar 31, 2024
JPMORGAN CHASE & CO0.00%-372--353Mar 31, 2024
ALLWORTH FINANCIAL LP0.00%-37--36,000Mar 31, 2024
NORTHERN TRUST CORP0.17%-75,013--71,262Mar 31, 2024
CREATIVE PLANNING0.05%-21,295--20,230Mar 31, 2024

As of Mar 31 2024, Cytosorbents's largest institutional buyer is CM MANAGEMENT, LLC. The company purchased 410.00K stocks of CTSO, valued at $783.75K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GRANAHAN INVESTMENT MANAGEMENT, LLC6.82%0.10%3,044,833-573,310-15.85%2,892,591Mar 31, 2024
SKYLANDS CAPITAL, LLC6.44%0.38%2,875,552-378,661-11.64%2,731,774Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.18%0.00%79,620-95,700-54.59%76,000Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP----56,570-100.00%-Mar 31, 2024
REGAL INVESTMENT ADVISORS LLC0.03%0.00%11,509-34,315-74.88%10,934Mar 31, 2024
BANK OF AMERICA CORP /DE/0.08%-36,898-29,882-44.75%35,053,000Mar 31, 2024
BANK OF NEW YORK MELLON CORP0.01%-3,640-18,787-83.77%3,458Mar 31, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----15,994-100.00%-Mar 31, 2024
STATE STREET CORP0.31%-140,293-10,800-7.15%133,278Mar 31, 2024
US BANCORP \DE\----10,000-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.08%-35,843-9,285-20.57%34,051Mar 31, 2024
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC0.05%0.00%23,166-7,500-24.46%22,008Mar 31, 2024
BLACKROCK INC.1.62%-722,435-3,885-0.53%686,313Mar 31, 2024
MORGAN STANLEY0.26%-116,385-3,593-2.99%110,566Mar 31, 2024
UBS GROUP AG0.00%-57-2,904-98.08%54Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----2,200-100.00%-Mar 31, 2024
SIMPLEX TRADING, LLC----1,459-100.00%-Mar 31, 2024
JOHNSON INVESTMENT COUNSEL INC0.04%0.00%19,387-584-2.92%18,418Mar 31, 2024
CHICAGO PARTNERS INVESTMENT GROUP LLC0.07%0.00%30,667-169-0.55%26,956Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.00%-31-5-13.89%29,000Mar 31, 2024

As of Mar 31 2024, Cytosorbents's biggest institutional seller is GRANAHAN INVESTMENT MANAGEMENT, LLC. The company sold -0.57M shares of CTSO, valued at $2.89M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANE STREET GROUP, LLC0.10%-46,65546,655100.00%44,322Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.04%-16,19816,198100.00%15,388Mar 31, 2024

Cytosorbents's largest new institutional shareholder by number of shares is JANE STREET GROUP, LLC, purchased 46.66K shares, valued at $44.32K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DIMENSIONAL FUND ADVISORS LP----56,570-100.00%-Mar 31, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----15,994-100.00%-Mar 31, 2024
US BANCORP \DE\----10,000-100.00%-Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----2,200-100.00%-Mar 31, 2024
SIMPLEX TRADING, LLC----1,459-100.00%-Mar 31, 2024

Cytosorbents's largest sold out institutional shareholder by shares sold is DIMENSIONAL FUND ADVISORS LP, sold -56.57K shares, valued at -, as of undefined.

Cytosorbents Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SPARROW FUNDS3.89%13,875--Feb 29, 2024
Jacob Funds Inc.0.86%197,940--Feb 29, 2024
Cushing Mutual Funds Trust0.74%21,447--Aug 31, 2023
WP Trust0.14%20,000--Feb 29, 2024
NEUBERGER BERMAN EQUITY FUNDS0.09%901,950366,40468.42%Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS0.07%35,641--Dec 31, 2023
ROYCE FUND0.06%349,000--Dec 31, 2023
FORUM FUNDS II0.05%45,502--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%6,431--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.01%64,033--Dec 31, 2023
VANGUARD INDEX FUNDS0.01%2,438,682568,23330.38%Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%1,039--Dec 31, 2023
Harbor ETF Trust0.00%7,979--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%346,23016,2154.91%Feb 29, 2024
Virtus Strategy Trust0.00%32,611--Dec 29, 2023
Calvert Variable Products, Inc.0.00%3,468--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%29,596--Dec 31, 2023
GPS Funds I0.00%4,203--Dec 31, 2023
ADVISORS' INNER CIRCLE FUND0.00%10,282--Jan 31, 2024
SunAmerica Specialty Series0.00%339--Apr 30, 2021
Voya VARIABLE PORTFOLIOS INC0.00%16,730--Dec 31, 2023
VANGUARD VARIABLE INSURANCE FUNDS0.00%23,517--Dec 31, 2023
AdvisorShares Trust0.00%913--Dec 29, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%1,173--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,304--Dec 31, 2023
Meeder Funds0.00%1,133--Mar 31, 2024
HC CAPITAL TRUST0.00%7,035--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%20,132--Feb 29, 2024
Goldman Sachs ETF Trust0.00%18,107--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%466--Dec 31, 2023
Virtus Investment Trust0.00%4,395--Dec 29, 2023
FIDELITY SALEM STREET TRUST0.00%306,404--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,634--Dec 31, 2023
VICTORY PORTFOLIOS0.00%2,951--Dec 31, 2023
ProFunds0.00%882--Jan 31, 2024
RYDEX SERIES FUNDS0.00%395--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%7,660--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%5,110--Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%23,60316,817247.82%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%1,259--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%141,061--Feb 29, 2024
PGIM ETF TRUST0.00%3,609--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%217--Dec 31, 2023
VALIC Co I0.00%15,284--Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%19,040--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%5,579--Jan 31, 2024
Guggenheim Active Allocation Fund0.00%245--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%5,500--Dec 31, 2023
PENN SERIES FUNDS INC0.00%1,100--Dec 29, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%2,081--Dec 31, 2023
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%7,469--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%39--Dec 31, 2023
TRUST FOR PROFESSIONAL MANAGERS0.00%8,7078,707-Feb 29, 2024
NORTHERN FUNDS0.00%22,145--Dec 29, 2023
Dimensional ETF Trust0.00%10,417--Jan 31, 2024
PROSHARES TRUST0.00%5,941--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%26,160--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%19,029--Jan 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%34,700--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%1,517--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%4,547--Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%22,219--Dec 31, 2023
Brighthouse Funds Trust II0.00%15,424--Dec 31, 2023
EQ ADVISORS TRUST0.00%7,170--Dec 31, 2023
iSHARES TRUST0.00%89,930--Feb 29, 2024
PACIFIC SELECT FUND0.00%14,860--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%50--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%3,625--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%300--Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%5,384--Dec 31, 2023
PRINCIPAL FUNDS, INC.0.00%6,300--Feb 29, 2024
Bridge Builder Trust0.00%5,523--Dec 31, 2023
BLACKROCK FUNDS0.00%5,026--Feb 29, 2024
John Hancock Funds II0.00%4,966--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%5,500--Feb 29, 2024

Cytosorbents's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 13.88K shares, compromising 3.89% of its total assets.

Cytosorbents Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2426-49.02%
31 Dec, 2351-5.56%
30 Sep, 2354-6.90%
30 Jun, 2358-3.33%
31 Mar, 236015.38%
31 Dec, 2252-3.70%
30 Sep, 2254-23.94%
30 Jun, 2271-16.47%
31 Mar, 2285-5.56%
31 Dec, 2190-5.26%
30 Sep, 2195-4.04%
30 Jun, 21994.21%
31 Mar, 21953.26%
31 Dec, 2092-2.13%
30 Sep, 20942.17%
30 Jun, 209213.58%
31 Mar, 208117.39%
31 Dec, 19691.47%
30 Sep, 1968-
30 Jun, 1968-10.53%
31 Mar, 1976-12.64%
31 Dec, 18878.75%
30 Sep, 18802.56%
30 Jun, 187850.00%
31 Mar, 185213.04%
31 Dec, 174639.39%
30 Sep, 17333.13%
30 Jun, 1732-5.88%
31 Mar, 1734-8.11%
31 Dec, 16375.71%
30 Sep, 1635-
30 Jun, 16356.06%
31 Mar, 1633-19.51%
31 Dec, 154120.59%
30 Sep, 15349.68%
30 Jun, 153110.71%
31 Mar, 1528211.11%
31 Dec, 149-

As of 31 Mar 24, 26 institutions are holding Cytosorbents's shares, representing a decrease of -49.02% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 247,507,341-58.15%
31 Dec, 2317,940,75818.13%
30 Sep, 2315,187,9430.09%
30 Jun, 2315,173,5290.40%
31 Mar, 2315,113,2573.36%
31 Dec, 2214,621,373-1.37%
30 Sep, 2214,825,196-3.90%
30 Jun, 2215,426,063-14.44%
31 Mar, 2218,029,0501.32%
31 Dec, 2117,794,041-3.14%
30 Sep, 2118,371,1055.30%
30 Jun, 2117,446,8270.34%
31 Mar, 2117,386,939-0.68%
31 Dec, 2017,506,5692.36%
30 Sep, 2017,102,77952.81%
30 Jun, 2011,191,86014.13%
31 Mar, 209,806,24010.18%
31 Dec, 198,899,8966.09%
30 Sep, 198,389,024-0.79%
30 Jun, 198,456,175-0.45%
31 Mar, 198,494,421-1.67%
31 Dec, 188,638,2765.63%
30 Sep, 188,177,9674.49%
30 Jun, 187,826,543105.41%
31 Mar, 183,810,16521.16%
31 Dec, 173,144,75436.88%
30 Sep, 172,297,53323.23%
30 Jun, 171,864,432-22.67%
31 Mar, 172,410,90152.79%
31 Dec, 161,577,8810.90%
30 Sep, 161,563,833-10.66%
30 Jun, 161,750,45027.89%
31 Mar, 161,368,7281.87%
31 Dec, 151,343,5763.02%
30 Sep, 151,304,16510.36%
30 Jun, 151,181,72029.79%
31 Mar, 15910,479130.95%
31 Dec, 14394,240-

Cytosorbents (CTSO) has 7.51M shares outstanding as of 31 Mar 24, down -58.15% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2416.81%1.03%
31 Dec, 2340.43%3.40%
30 Sep, 2334.51%2.86%
30 Jun, 2334.74%2.90%
31 Mar, 2334.60%2.44%
31 Dec, 2237.67%3.26%
30 Sep, 2234.00%2.71%
30 Jun, 2235.41%2.06%
31 Mar, 2241.46%2.48%
31 Dec, 2140.93%2.28%
30 Sep, 2142.33%2.61%
30 Jun, 2140.28%2.49%
31 Mar, 2140.21%2.27%
31 Dec, 2042.09%2.49%
30 Sep, 2041.12%4.37%
30 Jun, 2030.68%3.68%
31 Mar, 2028.86%4.21%
31 Dec, 1926.19%3.90%
30 Sep, 1925.92%3.77%
30 Jun, 1926.21%3.70%
31 Mar, 1926.60%3.63%
31 Dec, 1827.05%3.96%
30 Sep, 1826.12%3.92%
30 Jun, 1825.83%15.33%
31 Mar, 1812.98%11.31%
31 Dec, 1710.71%16.15%
30 Sep, 178.15%18.31%
30 Jun, 176.67%7.46%
31 Mar, 179.45%24.70%
31 Dec, 166.19%16.38%
30 Sep, 166.15%12.96%
30 Jun, 166.89%21.89%
31 Mar, 165.61%18.50%
31 Dec, 155.51%20.29%
30 Sep, 155.21%22.88%
30 Jun, 154.77%34.25%
31 Mar, 153.73%49.68%
31 Dec, 142.74%-

As of 31 Mar 24, Cytosorbents is held by 16.81% institutional shareholders, representing a 1.03% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 246-70.00%
31 Dec, 232011.11%
30 Sep, 2318-33.33%
30 Jun, 232722.73%
31 Mar, 23224.76%
31 Dec, 222131.25%
30 Sep, 2216-51.52%
30 Jun, 2233-13.16%
31 Mar, 2238-15.56%
31 Dec, 214515.38%
30 Sep, 2139-
30 Jun, 2139-13.33%
31 Mar, 2145-4.26%
31 Dec, 2047-7.84%
30 Sep, 2051-19.05%
30 Jun, 206334.04%
31 Mar, 204734.29%
31 Dec, 193512.90%
30 Sep, 19313.33%
30 Jun, 1930-9.09%
31 Mar, 1933-19.51%
31 Dec, 18415.13%
30 Sep, 1839-33.90%
30 Jun, 185984.38%
31 Mar, 1832-5.88%
31 Dec, 1734142.86%
30 Sep, 171427.27%
30 Jun, 1711-45.00%
31 Mar, 172011.11%
31 Dec, 1618-
30 Sep, 1618-
30 Jun, 161838.46%
31 Mar, 1613-45.83%
31 Dec, 152471.43%
30 Sep, 1514-22.22%
30 Jun, 1518-25.00%
31 Mar, 1524166.67%
31 Dec, 149-

6 institutional shareholders have increased their position in CTSO stock as of 31 Mar 24 compared to 20 in the previous quarter (a -70.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 246-57.14%
31 Dec, 2314-12.50%
30 Sep, 231660.00%
30 Jun, 2310-41.18%
31 Mar, 2317-
31 Dec, 22176.25%
30 Sep, 2216-30.43%
30 Jun, 2223-14.81%
31 Mar, 22278.00%
31 Dec, 2125-7.41%
30 Sep, 2127-28.95%
30 Jun, 213835.71%
31 Mar, 212847.37%
31 Dec, 2019-9.52%
30 Sep, 202190.91%
30 Jun, 2011-38.89%
31 Mar, 2018-5.26%
31 Dec, 1919-
30 Sep, 1919-5.00%
30 Jun, 1920-9.09%
31 Mar, 1922-
31 Dec, 1822-
30 Sep, 1822340.00%
30 Jun, 185-44.44%
31 Mar, 18980.00%
31 Dec, 175-16.67%
30 Sep, 176-57.14%
30 Jun, 171455.56%
31 Mar, 17912.50%
31 Dec, 168-
30 Sep, 16860.00%
30 Jun, 165-16.67%
31 Mar, 166-
31 Dec, 156-25.00%
30 Sep, 158100.00%
30 Jun, 154-
31 Mar, 15--
31 Dec, 14--

6 institutional shareholders have reduced their position in CTSO stock as of 31 Mar 24 compared to 14 in the previous quarter (a -57.14% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2426-49.02%7,507,341-58.15%16.81%1.03%6-70.00%6-57.14%
31 Dec, 2351-5.56%17,940,75818.13%40.43%3.40%2011.11%14-12.50%
30 Sep, 2354-6.90%15,187,9430.09%34.51%2.86%18-33.33%1660.00%
30 Jun, 2358-3.33%15,173,5290.40%34.74%2.90%2722.73%10-41.18%
31 Mar, 236015.38%15,113,2573.36%34.60%2.44%224.76%17-
31 Dec, 2252-3.70%14,621,373-1.37%37.67%3.26%2131.25%176.25%
30 Sep, 2254-23.94%14,825,196-3.90%34.00%2.71%16-51.52%16-30.43%
30 Jun, 2271-16.47%15,426,063-14.44%35.41%2.06%33-13.16%23-14.81%
31 Mar, 2285-5.56%18,029,0501.32%41.46%2.48%38-15.56%278.00%
31 Dec, 2190-5.26%17,794,041-3.14%40.93%2.28%4515.38%25-7.41%
30 Sep, 2195-4.04%18,371,1055.30%42.33%2.61%39-27-28.95%
30 Jun, 21994.21%17,446,8270.34%40.28%2.49%39-13.33%3835.71%
31 Mar, 21953.26%17,386,939-0.68%40.21%2.27%45-4.26%2847.37%
31 Dec, 2092-2.13%17,506,5692.36%42.09%2.49%47-7.84%19-9.52%
30 Sep, 20942.17%17,102,77952.81%41.12%4.37%51-19.05%2190.91%
30 Jun, 209213.58%11,191,86014.13%30.68%3.68%6334.04%11-38.89%
31 Mar, 208117.39%9,806,24010.18%28.86%4.21%4734.29%18-5.26%
31 Dec, 19691.47%8,899,8966.09%26.19%3.90%3512.90%19-
30 Sep, 1968-8,389,024-0.79%25.92%3.77%313.33%19-5.00%
30 Jun, 1968-10.53%8,456,175-0.45%26.21%3.70%30-9.09%20-9.09%
31 Mar, 1976-12.64%8,494,421-1.67%26.60%3.63%33-19.51%22-
31 Dec, 18878.75%8,638,2765.63%27.05%3.96%415.13%22-
30 Sep, 18802.56%8,177,9674.49%26.12%3.92%39-33.90%22340.00%
30 Jun, 187850.00%7,826,543105.41%25.83%15.33%5984.38%5-44.44%
31 Mar, 185213.04%3,810,16521.16%12.98%11.31%32-5.88%980.00%
31 Dec, 174639.39%3,144,75436.88%10.71%16.15%34142.86%5-16.67%
30 Sep, 17333.13%2,297,53323.23%8.15%18.31%1427.27%6-57.14%
30 Jun, 1732-5.88%1,864,432-22.67%6.67%7.46%11-45.00%1455.56%
31 Mar, 1734-8.11%2,410,90152.79%9.45%24.70%2011.11%912.50%
31 Dec, 16375.71%1,577,8810.90%6.19%16.38%18-8-
30 Sep, 1635-1,563,833-10.66%6.15%12.96%18-860.00%
30 Jun, 16356.06%1,750,45027.89%6.89%21.89%1838.46%5-16.67%
31 Mar, 1633-19.51%1,368,7281.87%5.61%18.50%13-45.83%6-
31 Dec, 154120.59%1,343,5763.02%5.51%20.29%2471.43%6-25.00%
30 Sep, 15349.68%1,304,16510.36%5.21%22.88%14-22.22%8100.00%
30 Jun, 153110.71%1,181,72029.79%4.77%34.25%18-25.00%4-
31 Mar, 1528211.11%910,479130.95%3.73%49.68%24166.67%--
31 Dec, 149-394,240-2.74%-9---

Cytosorbents Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 15, 2023Sobel Alan D.director-P-PurchaseBuy22,557$1.33$30.00K101,857
Dec 15, 2023Sobel Alan D.director-P-PurchaseBuy7,894$2.00$15.79K7,894
Dec 15, 2023Deliargyris Efthymiosofficer Chief Medical OfficerP-PurchaseBuy22,557$1.33$30.00K348,433
Dec 15, 2023Deliargyris Efthymiosofficer Chief Medical OfficerP-PurchaseBuy7,894$2.00$15.79K7,894

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 15, 2023Sobel Alan D.director-P-PurchaseBuy22,557$1.33$30.00K101,857
Dec 15, 2023Sobel Alan D.director-P-PurchaseBuy7,894$2.00$15.79K7,894
Dec 15, 2023Deliargyris Efthymiosofficer Chief Medical OfficerP-PurchaseBuy22,557$1.33$30.00K348,433
Dec 15, 2023Deliargyris Efthymiosofficer Chief Medical OfficerP-PurchaseBuy7,894$2.00$15.79K7,894

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 04, 2024Jones Edward Raymonddirector-A-AwardBuy22,000$0.95$21.01K22,000
Apr 04, 2024Deliargyris Efthymiosofficer Chief Medical OfficerA-AwardBuy61,000--409,433
Apr 04, 2024Deliargyris Efthymiosofficer Chief Medical OfficerA-AwardBuy86,000$0.95$82.13K86,000
Apr 04, 2024Sobel Alan D.director-A-AwardBuy22,000$0.95$21.01K22,000
Apr 04, 2024BLOCH KATHLEEN P.officer Chief Financial OfficerA-AwardBuy65,000--532,941
Apr 04, 2024BLOCH KATHLEEN P.officer Chief Financial OfficerA-AwardBuy87,000$0.95$83.08K87,000
Apr 04, 2024BATOR MICHAEL G.director-A-AwardBuy44,000$0.95$42.02K44,000
Apr 04, 2024Capponi Vincentofficer President and COOA-AwardBuy81,000--665,134
Apr 04, 2024Capponi Vincentofficer President and COOA-AwardBuy101,000$0.95$96.45K101,000
Apr 04, 2024Kim Jinydirector-A-AwardBuy22,000$0.95$21.01K22,000
Apr 04, 2024Chan Phillip P.director, officer Chief Executive OfficerA-AwardBuy96,000--1,164,704
Apr 04, 2024Chan Phillip P.director, officer Chief Executive OfficerA-AwardBuy124,000$0.95$118.42K124,000
Apr 02, 2024Deliargyris Efthymiosofficer Chief Medical OfficerA-AwardBuy47,088$0.95$44.73K47,088
Apr 02, 2024Capponi Vincentofficer President and COOA-AwardBuy48,923$0.95$46.48K48,923
Apr 02, 2024BLOCH KATHLEEN P.officer Chief Financial OfficerA-AwardBuy49,038$0.95$46.59K49,038
Apr 02, 2024Chan Phillip P.director, officer Chief Executive OfficerA-AwardBuy129,998$0.95$123.50K129,998
Dec 15, 2023Sobel Alan D.director-P-PurchaseBuy22,557$1.33$30.00K101,857
Dec 15, 2023Sobel Alan D.director-P-PurchaseBuy7,894$2.00$15.79K7,894
Dec 15, 2023Deliargyris Efthymiosofficer Chief Medical OfficerP-PurchaseBuy22,557$1.33$30.00K348,433
Dec 15, 2023Deliargyris Efthymiosofficer Chief Medical OfficerP-PurchaseBuy7,894$2.00$15.79K7,894

The last insider buy of CTSO was made by Sobel Alan D. on Dec 15 2023, buying 22,557 shares at $1.33 per share (worth $30.00K).

Cytosorbents Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 202316--
Q3 2023174425.00%
Q2 202382400.00%
Q1 202322100.00%
Q4 20223--
Q3 202210--
Q2 202211--
Q1 20221--
Q4 202162300.00%
Q3 20211250.00%
Q2 202112--
Q4 20202366.67%
Q3 202031300.00%
Q2 202054125.00%
Q1 2020123400.00%
Q4 20193--
Q3 2019173566.67%
Q2 201932150.00%
Q1 20195--
Q4 201821200.00%

16 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cytosorbents's insiders, as of Q4 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 202316--
Q3 20233--
Q2 20236--
Q1 2023---
Q4 20223--
Q3 20221--
Q2 202210--
Q1 2022---
Q4 20215--
Q3 2021-1-
Q2 2021---
Q4 2020-1-
Q3 2020---
Q2 2020-1-
Q1 2020-1-
Q4 20193--
Q3 20192--
Q2 20191--
Q1 2019---
Q4 2018-1-

As of Q4 2023, Insider owners conducted 16 open market buy trades and 0 open market sell trades of Cytosorbents's stocks.

Cytosorbents Peer Ownership


TickerCompany
TELATELA Bio, Inc.
FNAParagon 28, Inc.
CLPTClearPoint Neuro, Inc.
OFIXOrthofix Medical Inc.
LIVNLivaNova PLC
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
LUNGPulmonx Corporation
APYXApyx Medical Corporation
OSAProSomnus, Inc. Common Stock
KIDSOrthoPediatrics Corp.
CVRXCVRx, Inc.
AORTArtivion, Inc.
INGNInogen, Inc.

CTSO Ownership FAQ


Cytosorbents is owned by institutional shareholders (16.81%), insiders (3.20%), and public (79.99%). The largest institutional shareholder of Cytosorbents is AVENIR CORP (7.10% of total shares) and the top mutual fund owner is SPARROW FUNDS (3.89% of total shares).

Cytosorbents's major institutional shareholders are AVENIR CORP, GRANAHAN INVESTMENT MANAGEMENT, LLC, SKYLANDS CAPITAL, LLC, VANGUARD GROUP INC, and NEUBERGER BERMAN GROUP LLC. The top five shareholders own together 29.01% of the company's share outstanding.

As of Mar 2024, there are 26 institutional shareholders of Cytosorbents.

AVENIR CORP owns 3.17M shares of Cytosorbents, representing 7.10% of the company's total shares outstanding, valued at $3.01M (as of Mar 2024).

As of Mar 2024, GRANAHAN INVESTMENT MANAGEMENT, LLC holds 3.04M shares of Cytosorbents (CTSO), compromising 6.82% of the company, valued at $2.89M.

SKYLANDS CAPITAL, LLC is the third largest holder of Cytosorbents. The company owns 2.88M of the company's shares outstanding (worth $2.73M).